What is the recommended approach to initiating insulin therapy in an adult patient with end‑stage renal disease?

Insulin Initiation in ESRD Patients

Start with a conservative basal insulin dose of 0.2–0.3 units/kg/day in patients with end-stage renal disease, which is approximately 25–50% lower than standard dosing, due to decreased insulin clearance and increased hypoglycemia risk.

Rationale for Dose Reduction in ESRD

ESRD fundamentally alters insulin pharmacokinetics through multiple mechanisms:

• Decreased renal insulin degradation leads to prolonged insulin half-life
• Reduced insulin clearance increases hypoglycemia risk
• Insulin resistance paradoxically coexists with decreased insulin requirements 1, 2

The most recent high-quality guideline evidence supports conservative initiation. Lower starting insulin doses (0.2 to 0.3 units/kg/day) are specifically recommended for patients with renal failure 1. This represents a substantial reduction from the typical 0.4–0.5 units/kg/day used in patients with normal renal function.

Practical Initiation Strategy

Step 1: Calculate Initial Dose

• Use 0.2–0.3 units/kg/day as total daily dose (TDD)
• For a 70 kg patient: 14–21 units/day total
• Distribute as 40–50% basal insulin and remainder as prandial if needed 1

Step 2: Choose Insulin Regimen

Start with basal insulin alone as the preferred approach 3:

• Long-acting insulin analogs (glargine, detemir, degludec) are preferred
• Once-daily dosing minimizes complexity and injection burden
• Basal-only regimens reduce hypoglycemia risk in this vulnerable population 4

Step 3: Titration Approach

Titrate conservatively to avoid hypoglycemia 3:

• Adjust by 2 units every 3–7 days based on fasting glucose
• Target fasting glucose: 90–150 mg/dL (5.0–8.3 mmol/L) 4
• More relaxed targets may be appropriate given hypoglycemia risk

Critical Considerations for Dialysis Patients

Hemodialysis-Specific Adjustments

Reduce basal insulin dose by up to 25% on hemodialysis days to prevent intradialytic and post-dialysis hypoglycemia 5. The dialysis procedure itself increases hypoglycemia risk through:

• Glucose removal during dialysis
• Clearance of counter-regulatory hormones
• Variable nutritional intake around dialysis sessions

Peritoneal Dialysis Considerations

For patients on peritoneal dialysis using dextrose-based dialysate 5:

• Systemic dextrose absorption may increase insulin requirements by up to 30%
• Intraperitoneal insulin administration is possible but requires dose increases due to tubing loss and dilution
• Subcutaneous administration remains the standard approach

Monitoring Strategy

Intensive glucose monitoring is mandatory during insulin initiation in ESRD 3, 2:

• Check fasting glucose daily initially
• Monitor for hypoglycemia symptoms (noting that awareness may be impaired)
• Measure glucose before and after dialysis sessions
• Consider continuous glucose monitoring if available

Hypoglycemia Management

Establish clear thresholds for intervention 6:

• Immediate treatment for glucose <70 mg/dL (3.9 mmol/L)
• Contact provider for glucose 70–100 mg/dL (may need dose reduction)
• Reduce insulin dose by 2 units if ≥2 readings/week <80 mg/dL 4

Common Pitfalls to Avoid

1. Using standard weight-based dosing: This leads to excessive insulin exposure and severe hypoglycemia in ESRD
2. Aggressive titration: Rapid dose increases cause delayed hypoglycemia due to prolonged insulin action
3. Ignoring dialysis schedules: Failing to reduce insulin on dialysis days increases hypoglycemia risk substantially 5
4. Overlooking nutritional status: Protein-energy wasting is common in ESRD and further reduces insulin requirements 7

Alternative Agents Before Insulin

While insulin is often necessary in ESRD, consider that 3, 8:

• Metformin is contraindicated when eGFR <30 mL/min/1.73 m²
• Most oral agents require dose adjustment or discontinuation
• Insulin becomes the preferred agent for glycemic control in advanced CKD 7

When to Add Prandial Insulin

Only add mealtime insulin if basal insulin alone fails to achieve targets 4, 1:

• Start with one prandial dose at the largest meal
• Use 2–4 units of rapid-acting insulin initially
• Titrate based on 2-hour postprandial glucose
• Consider simplified correction scales rather than complex carbohydrate counting given the complexity of ESRD management

The key principle is conservative initiation with meticulous monitoring, accepting slightly higher glucose targets to prioritize avoidance of hypoglycemia, which carries substantial morbidity and mortality risk in this population 3, 7, 2.